AGILE THERAPEUTICS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash inventory reserve
Depreciation
Amortization
Loss on disposition of assets
Noncash stock-based compensation
Noncash amortization of deferred financing costs
Unrealized gain on warrants
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other assets
Accounts payable and accrued expenses
Lease liability
Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable securities
Sales and maturities of marketable securities
Acquisition of property and equipment
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Proceeds from issuance of preferred stock in registered direct offering, net of offering costs
Proceeds from At-the-Market sales of common stock, net of offering costs
Proceeds from issuance of common stock in private placement, net of offering costs
Proceeds from issuance of common stock in public offering, net of offering costs
Proceeds from issuance of long-term debt
Repayments of long-term debt
Debt financing costs paid
Proceeds from exercise of stock options
Repayments of note payable
Net cash provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of noncash financing activities
Warrants issued in connection with long-term debt
Operating right-of-use assets obtained in exchange for new operating lease liabilities
Supplemental cash flow information
Interest paid
Property and equipment purchases included in accounts payable

Comments